Information Letter on Tasigna®
2009.09.15
Active substance: nilotinib
The Federal Institute for Drugs and Medical Devices (BfArM) requests consideration of the Information letter concerning the medicinal product Tasigna®
Download DHPC/Information letter , Download_VeroeffentlichtAm_EN